Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2021
Antengene and Calithera enter global CB-708 licensing agreement
Antengene and Calithera announced an exclusive licensing agreement for the global development and commercialization of CB-708 (ATG-037). Antengene will lead development and commercialization; Calithera is eligible for an upfront payment, milestone payments, and tiered royalties.
2020
Calithera appoints Scott Garland to its board
Calithera Biosciences announced Scott Garland's appointment to its board of directors.